Medtronic (MDT) Tops Q4 EPS by 4c; guides below

Medtronic (NYSE: MDT) reported Q4 EPS of $1.62, $0.04 better than the analyst estimate of $1.58. Revenue for the quarter came in at $8.93 billion versus the consensus estimate of $8.82 billion.

GUIDANCE:

Medtronic sees FY2026 EPS of $5.50-$5.60, versus the consensus of $5.83. The company is guiding to FY26 organic revenue growth of approximately 5%.

For earnings history and earnings-related data on Medtronic (MDT) click here.

You May Also Be Interested In

• Medtronic (MDT) Tops Q1 EPS by 6c, Beats on Revenue; Offers FY27 EPS Guidance
• MiniMed Group (MMED) PT Raised to $28 at BTIG
• lululemon athletica (LULU) call put ratio 1 call to 1.3 puts into quarter results